These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18345993)

  • 1. An assessment of the ocular safety of inactive excipients following sub-tenon injection in rabbits.
    Younis HS; Shawer M; Palacio K; Gukasyan HJ; Stevens GJ; Evering W
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):206-16. PubMed ID: 18345993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety Assessment of Formulation Vehicles Following Intravitreal Administration in Rabbits.
    Aguirre SA; Gukasyan HJ; Younis HS; Huang W
    Pharm Res; 2018 Jul; 35(9):173. PubMed ID: 29987391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of the ocular safety of excipient maleic acid following intravitreal injection in rabbits.
    Aguirre SA; Collette W; Gukasyan HJ; Huang W
    Toxicol Pathol; 2012 Jul; 40(5):797-806. PubMed ID: 22552388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models.
    Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I
    Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
    Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
    Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Labrasol/Labrafil/Transcutol (4/4/2, v/v/v) as a non-clinical vehicle for poorly water-soluble compounds after 4-week oral toxicity study in Wistar rats.
    Delongeas JL; de Conchard GV; Beamonte A; Bertheux H; Spire C; Maisonneuve C; Becourt-Lhote N; Goldfain-Blanc F; Claude N
    Regul Toxicol Pharmacol; 2010; 57(2-3):284-90. PubMed ID: 20347907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.
    Shehab N; Lewis CL; Streetman DD; Donn SM
    Pediatr Crit Care Med; 2009 Mar; 10(2):256-9. PubMed ID: 19188870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular irritation evaluation of benzalkonium chloride in rabbits.
    Britton B; Hervey R; Kasten K; Gregg S; McDonald T
    Ophthalmic Surg; 1976; 7(3):46-55. PubMed ID: 980377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rat nasal lavage biomarkers to assess preclinical irritation potential of nasal drug formulations and excipients.
    Mathias NR; Moench P; Heran C; Hussain MA; Smith RL
    J Pharm Sci; 2009 Feb; 98(2):495-502. PubMed ID: 18506818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Local Tolerability to 5 Long-acting Drug Nanosuspensions with Different Stabilizing Excipients, Following a Single Intramuscular Administration in the Rat.
    Chamanza R; Darville N; van Heerden M; De Jonghe S
    Toxicol Pathol; 2018 Jan; 46(1):85-100. PubMed ID: 29096596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of particles, small molecules and polymeric formulation excipients in the suprachoroidal space after microneedle injection.
    Chiang B; Venugopal N; Edelhauser HF; Prausnitz MR
    Exp Eye Res; 2016 Dec; 153():101-109. PubMed ID: 27742547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental toxicity of polyethylene glycol-g-polyvinyl alcohol grafted copolymer in rats and rabbits.
    Heuschmid FF; Schneider S; Schuster P; Lauer B; van Ravenzwaay B
    Food Chem Toxicol; 2013 Jul; 51 Suppl 1():S14-23. PubMed ID: 23298676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on selecting the suitable solubilizing excipients for Shengmai injection].
    Zhang SF; Yan D; Tang HY; Li HB; Wang YS; Xiao XH; Yang M
    Zhong Yao Cai; 2009 Jun; 32(6):969-72. PubMed ID: 19764337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subchronic toxicity of polyethylene glycol-g-polyvinyl alcohol grafted copolymer.
    Heuschmid FF; Schuster P; Lauer B; Buesen R; Mellert W; Groeters S; van Ravenzwaay B
    Food Chem Toxicol; 2013 Jul; 51 Suppl 1():S7-S13. PubMed ID: 23306789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermal and ocular irritation and skin sensitization studies of fullerene C60 nanoparticles.
    Ema M; Matsuda A; Kobayashi N; Naya M; Nakanishi J
    Cutan Ocul Toxicol; 2013 Jun; 32(2):128-34. PubMed ID: 23050631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boosting drug bioavailability in men but not women through the action of an excipient.
    Mai Y; Ashiru-Oredope DAI; Yao Z; Dou L; Madla CM; Taherali F; Murdan S; Basit AW
    Int J Pharm; 2020 Sep; 587():119678. PubMed ID: 32710919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
    J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics.
    Singh-Joy SD; McLain VC
    Int J Toxicol; 2008; 27 Suppl 2():93-128. PubMed ID: 18830866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.